> Reagents, Immunoassay, Autoimmune, Connective Tissue, Scleroderma-70 Antibody
Reagents, Immunoassay, Autoimmune, Connective Tissue, Scleroderma-70 Antibody
Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (e.g., serum) to determine Scleroderma-70 ([Scl-70], DNA topoisomerase I) antibodies. Circulating Scl-70 antibodies are present in some autoimmune connective-tissue diseases, particularly in scleroderma and progressive systemic sclerosis.
Entry Terms : "Scleroderma-70 Antibody Determination Reagents" , "DNA Topoisomerase I Antibody Determination Reagents"
UMDC code : 20079
Corgenix UK Ltd
Corgenix UK Ltd
Diamedix Corporation and its forerunner, Cordis Laboratories, have been on the leading edge of medical diagnostic technologies for more than a quarter century. Throughout the years, Diamedix has continued to pioneer unique immunodiagnostic innovations in its products, procedures, and in the development of integrated instrument and reagent systems for both autoimmune and infectious disease detection. Today, Diamedix maintains its tradition of developing product systems designed specifically to simplify and improve diagnostic testing in ways that enhance efficiency and accuracy, while promoting economy.
Hemagen Diagnostics Inc
Hemagen Inc. was founded in 1985 by a group of scientists from the Boston University School of Medicine.
TheraTest Laboratories Inc
TheraTest Laboratories, Inc.™ was founded in 1988 by a group of eminent clinical rheumatologists and laboratory investigators from the University of Illinois at Chicago. They realized the need to develop accurate, sensitive and reproducible methods of detecting and measuring autoantibodies in their patients.